Virtus ETF Advisers LLC Kinnate Biopharma Inc. Transaction History

Virtus ETF Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.43 - $13.0 $68,237 - $119,392	-9,184 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.73 - $17.99 $4,181 - $9,732	-541 Reduced 5.56%	9,184 $103,000
Q4 2021 Feb 14, 2022	BUY	$16.5 - $25.48 $160,462 - $247,793	9,725 New	9,725 $172,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.